Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Condition: Advanced Pancreatic Cancer Intervention: Biological: Personalized neoantigen tumor vaccine Sponsor: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Hospitals | Pancreas | Pancreatic Cancer | Research | Vaccines